JP2024532780A5 - - Google Patents

Info

Publication number
JP2024532780A5
JP2024532780A5 JP2024508498A JP2024508498A JP2024532780A5 JP 2024532780 A5 JP2024532780 A5 JP 2024532780A5 JP 2024508498 A JP2024508498 A JP 2024508498A JP 2024508498 A JP2024508498 A JP 2024508498A JP 2024532780 A5 JP2024532780 A5 JP 2024532780A5
Authority
JP
Japan
Prior art keywords
pyridine
methylmorpholine
cancer
group
trifluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024508498A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024532780A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/074925 external-priority patent/WO2023019259A1/en
Publication of JP2024532780A publication Critical patent/JP2024532780A/ja
Publication of JP2024532780A5 publication Critical patent/JP2024532780A5/ja
Pending legal-status Critical Current

Links

JP2024508498A 2021-08-13 2022-08-12 Vps34阻害剤を使用した併用療法 Pending JP2024532780A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163232983P 2021-08-13 2021-08-13
US63/232,983 2021-08-13
US202263317500P 2022-03-07 2022-03-07
US63/317,500 2022-03-07
PCT/US2022/074925 WO2023019259A1 (en) 2021-08-13 2022-08-12 Combination therapy of vps34 inhibitors and sting agonist for use in the treatment of cancer

Publications (2)

Publication Number Publication Date
JP2024532780A JP2024532780A (ja) 2024-09-10
JP2024532780A5 true JP2024532780A5 (cg-RX-API-DMAC7.html) 2025-08-18

Family

ID=83188606

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024508498A Pending JP2024532780A (ja) 2021-08-13 2022-08-12 Vps34阻害剤を使用した併用療法

Country Status (7)

Country Link
US (1) US20250127790A1 (cg-RX-API-DMAC7.html)
EP (1) EP4384180A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024532780A (cg-RX-API-DMAC7.html)
AU (1) AU2022326573A1 (cg-RX-API-DMAC7.html)
CA (1) CA3228766A1 (cg-RX-API-DMAC7.html)
TW (1) TW202320797A (cg-RX-API-DMAC7.html)
WO (1) WO2023019259A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102708177B1 (ko) 2018-01-31 2024-09-23 데시페라 파마슈티칼스, 엘엘씨. 위장관 기질 종양의 치료를 위한 병용 요법
GB2630970A (en) * 2023-06-15 2024-12-18 Duke Street Bio Ltd PARP1 inhibitor compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU24377B1 (es) * 2013-05-18 2018-12-05 Aduro Biotech Inc Dinucléotidos de purina cíclicos y composiciones de los mismos útiles para inducir la producción de interferón de tipo i dependientes de sting
WO2015108881A1 (en) * 2014-01-14 2015-07-23 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
PT3416957T (pt) 2016-02-19 2020-09-25 Sprint Bioscience Ab Compostos 6-heterociclil-4-morfolin-4-ilpiridin-2-ona úteis para o tratamento do cancro e da diabetes
IL302356A (en) * 2017-08-23 2023-06-01 Sprint Bioscience Ab Pyridylpyridone compounds
PL3672948T3 (pl) * 2017-08-23 2022-12-05 Sprint Bioscience Ab Związki pirydynoamino-pirydonu i pirymidynoamino-pirydonu
WO2020008046A1 (en) * 2018-07-06 2020-01-09 Sprint Bioscience Ab Biomarker

Similar Documents

Publication Publication Date Title
JP2025143253A (ja) Brm標的化化合物および関連使用方法
US7838524B2 (en) Substituted pyrazolyl urea derivatives useful in the treatment of cancer
JP2021119196A5 (cg-RX-API-DMAC7.html)
RU2018123825A (ru) Соединения и способы для модуляции киназ, и показания для этого
JP2022531801A5 (cg-RX-API-DMAC7.html)
TW200534853A (en) Synergistic methods and compositions for treating cancer
RU2018131766A (ru) 6-гетероциклил-4-морфолин-4-илпиридин-2-оны, пригодные для лечения рака и диабета
KR102359759B1 (ko) 세린/트레오닌 키나제 저해제
JP2017505794A5 (cg-RX-API-DMAC7.html)
JP2012525395A5 (cg-RX-API-DMAC7.html)
EA013231B1 (ru) Замещенные амидные производные в качестве ингибиторов протеинкиназы
JP2014500308A (ja) Vps34阻害剤としてのビヘテロアリール化合物
MX2008006979A (es) Compuestos de urea utiles en el tratamiento contra el cancer.
EA029473B1 (ru) Применение ингибиторов pi3k для лечения острой и церебральной малярии
JP2020531488A5 (cg-RX-API-DMAC7.html)
RU2018131775A (ru) 6-арил-4-морфолин-1-илпиридоны, пригодные для лечения рака или диабета
JP7688042B2 (ja) アミド化合物およびその使用
FI3672948T3 (fi) Pyridiiniamiinipyridoni- ja pyrimidiiniamiinipyridoniyhdisteitä
JP2019505595A5 (cg-RX-API-DMAC7.html)
US20210355104A1 (en) Adenosine receptor binding compounds
JP2020531486A5 (cg-RX-API-DMAC7.html)
TW202430171A (zh) 雜芳基氨基化合物及其製備方法和應用
JP2020531487A5 (cg-RX-API-DMAC7.html)
JP2024532780A (ja) Vps34阻害剤を使用した併用療法
HRP20211999T1 (hr) Spojevi azaindolilpiridona i diazaindolilpiridona